Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2

Autor: Roberto Alonso, Sergio Gil-Manso, Pilar Catalán, Ignacio Sánchez-Arcilla, Marco Marzola, Rafael Correa-Rocha, Patricia Muñoz, Marjorie Pion, the Gregorio Marañón Microbiology-ID COVID-19 Study Group

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

The development of mRNA vaccines represented a significant achievement in response to the global health crisis during the SARS-CoV-2 pandemic. Evaluating vaccine efficacy entails identifying different anti-SARS-CoV-2 antibodies, such as total antibod

Externí odkaz: https://doaj.org/article/01e70eeca9024b2490ec99ce351d43ed

IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study

Autor: Sergio Gil-Manso, Roberto Alonso, Pilar Catalán, Ignacio Sánchez-Arcilla, Marco Marzola, Rafael Correa-Rocha, Marjorie Pion, Patricia Muñoz, Gregorio Marañón Microbiology-ID COVID-19 Study Group, Luis Alcalá, Teresa Aldámiz, Beatriz Álvarez, Ana Álvarez-Uría, Alexi Arias, Elena Bermúdez, Emilio Bouza, Sergio Buenesta do-Serrano, Almudena Burillo, Raquel Carrillo, Emilia Cercenado, Alejandro Cobos, Cristina Díez, Pilar Escribano, Agustín Estévez, Chiara Fanciulli, Alicia Galar, Mª Dolores García, Darío García de Viedma, Paloma Gijón, Adolfo González, Helmuth Guillén, Jesús Guinea, Marta Herranz, Álvaro Irigoyen, Laura Vanessa Haces, Martha Kestler, Juan Carlos López, Carmen Narcisa Losada, Marina Machado, Mercedes Marín, Pablo Martín-Rabadán, Andrea Molero-Salinas, Pedro Montilla, Patricia Muñoz, María Olmedo, Belén Padilla, Rosalía Palomino-Cabrera, María Palomo, María Jesús Pérez-Granda, Daniel Peñas-Utrilla, Laura Pérez-Lago, Leire Pérez, Elena Reigadas, Cristina Rincón, Belén Rodríguez, Sara Rodríguez, Cristina Rodríguez-Grande, Adriana Rojas, María Jesús Ruiz-Serrano, Carlos Sánchez, Mar Sánchez, Amadeo Sanz-Pérez, Julia Serrano, Francisco Tejerina, Maricela Valerio, Mª Cristina Veintimilla, Lara Vesperinas, Teresa Vicente, Sofíade la Villa

Publikováno v: Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)

IntroductionSince the COVID-19 outbreak, specific mRNA-based anti-SARS-CoV-2 vaccines have been developed and distributed worldwide. Because this is the first time that mRNA vaccines have been used, there are several questions regarding their capacit

Externí odkaz: https://doaj.org/article/fb0bdcc4626442ab9011659a5c02ff37

Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

Autor: Laura Pérez-Lago, Marina Machado, María de Mar Gómez-Ruiz, Pedro J. Sola-Campoy, Sergio Buenestado-Serrano, Victor Manuel de la Cueva-García, Marta Herranz, Cristina Andrés Zayas, Ignacio Sánchez-Arcilla, Rubén Francisco Flores-García, Nieves López-Fresneña, Sonia García de San José, Pilar Catalán, Patricia Muñoz, Darío García de Viedma

Publikováno v: Microbiology Spectrum, Vol 10, Iss 1 (2022)

ABSTRACT COVID-19 vaccination has proven to be effective at preventing symptomatic disease but there are scarce data to fully understand whether vaccinated individuals can still behave as SARS-CoV-2 transmission vectors. Based on viral genome sequenc

Externí odkaz: https://doaj.org/article/fd97d86cc6054815b18ef52992eb4a40

Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines

Autor: Sergio Gil-Manso, Diego Carbonell, Verónica Astrid Pérez-Fernández, Rocío López-Esteban, Roberto Alonso, Patricia Muñoz, Jordi Ochando, Ignacio Sánchez-Arcilla, Jose M Bellón, Rafael Correa-Rocha, Marjorie Pion

Publikováno v: Biomedicines, Vol 10, Iss 7, p 1676 (2022)

Vaccination against SARS-CoV-2 has become the main method of reducing mortality and severity of COVID-19. This work aims to study the evolution of the cellular and humoral responses conferred by two mRNA vaccines after two doses against SARS-CoV-2. O

Externí odkaz: https://doaj.org/article/abf825621e4742a88b7cff800b0109cc

Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines

Autor: José M. de la Fuente-Martín, Carmen Muñóz-Ruipérez, M.ª Luisa Rodríguez de la Pinta, Fernando Rescalvo-Santiago, Luis M. Cañibano Cimas, Jose Manuel Sanchez-Santos, Ricardo López-Pérez, M. Covadonga Caso-Pita, Marco Marzola-Payares, Miguel A. Alonso López, Marita P. Asmat-Inostrosa, Ignacio Sánchez-Arcilla, M. T. del Campo, M. Antonieta Ramírez Pérez, Jenry Borda Olivas, M. Asunción Blanco-González, José M. de la Torre-Robles, José L. Bravo-Grande, Itria Mirabella Villalobos, Marina Fernández-Escribano, Marina Hervella-Ordoñez, Miguel de Paula-Ortiz

Publikováno v: GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname
GREDOS: Repositorio Institucional de la Universidad de Salamanca
Universidad de Salamanca (USAL)

[EN] Trial Design: An interventional, phase 4, single group assignment, without masking (open label), preventive clinical trial was carried out in health workers with biological risk in their tasks, who have been filed as non-responders to convention

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73bfcc6b84a5d9e4c2fb52337463d8dc
https://doi.org/10.1016/j.vaccine.2020.12.006